HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Canada Guidance Sets Caps For Trace Metals In Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Canada’s public-health department may request testing data from firms with cosmetic products containing trace levels of heavy metals lead, arsenic, cadmium, mercury and antimony in concentrations above advised limits, with possible enforcement action to follow.

You may also be interested in...



ICCR Finalizing Nanotech, Trace Impurities Reports Following 6th Meeting

Regulators from the U.S., the EU, Canada and Japan are working to finalize reports on nanomaterials, trace impurities and animal testing alternatives following the sixth meeting of the International Cooperation on Cosmetics Regulation. The regulators came to agreements on the reports at the July 10-13 meeting in Rockville, Md., and will hammer out the details before releasing the reports this fall.

Canadian NGO Reports “Widespread” Heavy Metal Presence In Cosmetics

Environmental Defence Canada reports that 100% of 49 cosmetic products tested from Canadian women’s makeup bags contained “toxic” heavy metals, including lead, arsenic and cadmium.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018297

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel